top of page
PreferUS has been given the opportunity to re-launch the Shanghai Guolong Hospital with bringing our high-end orthopedic and cardiovascular models as well as western hospital management techniques. In order to do this, in May of 2018, PreferUS Executive Vice President of China Operations, David Farrick, was appointed the new CEO of the Shanghai Guolong Hospital. Farrick, who will be based in Shanghai, brings a wealth of experience in hospital management and will strongly contribute in elevating the Shanghai Guolong Hospital to an international standards hospital group. PreferUS Chief Executive Officer, Michael Franz, also serves as the Guolong Group CEO.
The Shanghai Guolong Hospital is located in the Pudong section of Shanghai. It operates with 102 beds and has a total bed capacity of 300. This hospital is one of four in the Ningxia Guolong Medical Development Group.
Guolong Hospital Group
In July of 2015, Ningxia Guolong Medical Development Group LTD., and PreferUS Healthcare entered into an equity partnership that has significantly expanded the capabilities of each partner. The partnership represents all three components of our product / service line offerings: consulting, management, and investment services. When PreferUS began its partnership with the Guolong Hospital Group, the Guolong consisted of two previous Yinchuan Hospitals and a hospital in Shanghai.
PreferUS has participated in the vision of Guolong's new 600-bed international standards hospital in Yinchuan. Through our strong relationship with Guolong, we have been included in the site selection, analyzing & selecting the architect firm, and contributing on the design input. In April of 2019, the new hospital officially opened and will serve not only the surrounding Yinchuan communities, but will be a destination for patients beyond the borders of China.
The PreferUS U.S. Immersion Program began with a group of nurses and administrators who visited the Oklahoma Heart Hospital. As of 2020, PreferUS has delivered U.S. based training for nearly 60 of the new hospital staff including doctors, nurses, and administrators. Additionally, within the new hospital, we have been focused on elevating professional nursing to transform healthcare delivery. We have successfully implemented many U.S. best-practices to improve the quality and safety of the patient population. The training has been instrumental in transforming care at the bedside and enhancing patient satisfaction as well as staff engagement and satisfaction.
Ningxia Guolong Medical Development Company, an established and growing Chinese company specializing in hospital management and services, is located in Yinchuan, China situated in the northwest part of China. In March of 1995, the first hospital in Yinchuan was opened and was quickly followed by a second facility. Guolong possesses future expansion plans in both Yinchuan and Shanghai where there is a strong demand for high quality medical services that Guolong and PreferUS Healthcare will partner to provide.
Yinchuan Guolong Hospital is the only hospital that has the secondary independent branch of orthopedics in the Ningxia Province and surrounding areas. They are known for outstanding surgical expertise in orthopedics and OBGYN. The hospital is one of only a few that are able to treat patients with scoliosis, joint replacement, complex spine and extremities fractures as well as severed finger reattachment in Ningxia.
At an annual rate of more than 4,500 patients, 2,100 of them being orthopedic cases, Yinchuan Guolong Hospital’s surgery success rate is 99.5%. After over 20 years of development, it has become the most popular specialized hospital in the Ningxia Province.
bottom of page